Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic liability to critically ill COVID-19 increased risk of HER2-positive breast cancer through the immune pathway: A Mendelian randomization study.

Medicine - 9 May 2025

Chen Jianfeng, Xin Bingyan, Tan Wenwen, Chen Zhilian, Zhang Lan, Zhu Xiaochuan

Abstract excerpt

The clinical management of patients with both coronavirus disease 2019 (COVID-19) and breast cancer remains a complex and unresolved issue that despite extensive discussion has not reached a consensus. In contemporary literature, the association between COVID-19 and HER2-positive breast cancer has received minimal attention. Genetic instruments for severe acute respiratory syndrome coronavirus 2 infection...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Critical Illness

Share to Erb-b2 Receptor Tyrosine Kinases

Share to Genetic Predisposition to Disease

Share to Genome-Wide Association Study

Share to Mendelian Randomization Analysis

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 40355230
DOI: 10.1097/MD.0000000000042372
PMCID: PMC12074039

Genes

CD27
CD38

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic liability to critically ill COVID-19 increased risk of HER2-positive breast cancer through the immune pathway: A Mendelian randomization study.PMID 40355230Read ↗

Causal effects of COVID-19 on cancer risk: A Mendelian randomization study.Semantic proximity Read ↗

Complex causal relationships between genetic predictions of 731 immune cell phenotypes and novel coronavirus: A two-sample Mendelian randomization analysis.Semantic proximity Read ↗

The Genetic Interface of Immunity and COVID-19: Insights from a Two-Sample Mendelian Randomization ApproachSemantic proximity Read ↗

Cancers and COVID-19 Risk: A Mendelian Randomization StudySemantic proximity Read ↗

Causal effect of COVID-19 on Alzheimer's disease: A Mendelian randomization study.Semantic proximity Read ↗

Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19.Semantic proximity Read ↗

Neutrophils cause critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatmentSemantic proximity Read ↗

Causal role of immune cells on cervical cancer onset revealed by two-sample Mendelian randomization study.Semantic proximity Read ↗

Exploring the protective association between COVID-19 infection and laryngeal cancer: insights from a Mendelian randomization study.Semantic proximity Read ↗

Immunocyte phenotype and breast cancer risk: A Mendel randomization analysis.Semantic proximity Read ↗

Circulating Cytokines and Coronavirus Disease: A Bi-Directional Mendelian Randomization StudySemantic proximity Read ↗

IL10RB as a key regulator of COVID-19 host susceptibility and severitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.